Industrial Scale Manufacturing and Downstream Processing of PLGA-Based Nanomedicines Suitable for Fully Continuous Operation

Despite the efficacy and potential therapeutic benefits that poly(lactic-co-glycolic acid) (PLGA) nanomedicine formulations can offer, challenges related to large-scale processing hamper their clinical and commercial development. Major hurdles for the launch of a polymeric nanocarrier product on the...

Descripción completa

Detalles Bibliográficos
Autores principales: Operti, Maria Camilla, Bernhardt, Alexander, Sincari, Vladimir, Jager, Eliezer, Grimm, Silko, Engel, Andrea, Hruby, Martin, Figdor, Carl Gustav, Tagit, Oya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8878443/
https://www.ncbi.nlm.nih.gov/pubmed/35214009
http://dx.doi.org/10.3390/pharmaceutics14020276

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8878443/
https://www.ncbi.nlm.nih.gov/pubmed/35214009
http://dx.doi.org/10.3390/pharmaceutics14020276

Ejemplares similares